A 26-year-old woman with a history of intravenous drug use was admitted to hospital with worsening pain in the right buttock radiating to the lateral part of the thigh and to the calf with no suspicion of cauda equina compression. Eventually, a diagnosis of sacroiliitis was made and appropriate antibiotics were administered. Provision of analgesia for this patient was difficult. On admission her medications included naltrexone, venlafaxine and tramadol. Initially naltrexone was continued and analgesia provided by epidural local anaesthetic and clonidine, intravenous ketamine and oral agents. After several days, naltrexone was ceased and opioids were used in addition to the other analgesics. The epidural analgesia was only partially effective, perhaps because of inadequate blockade of the L4-S1 nerve roots, which carry sensation from the sacroiliac joint.
Naltrexone is a long-acting opioid antagonist. If patients on naltrexone develop acute pain, the provision of opioid-based analgesia is difficult. We describe such a patient who developed sacroiliitis. Multimodal analgesia was required with a multidisciplinary approach.
CASE hISTOry
A 26-year-old female weighing approximately 70 kg was admitted to hospital with a history of worsening pain in the right buttock radiating to the lateral part of the thigh and the calf with no signs or symptoms of cauda equina compression. She was admitted by the rheumatology unit with a diagnosis of sciatica. She had first noticed discomfort nine days earlier, 24 hours after moving furniture, and had been confined to bed with pain for the last five days. A CT scan performed prior to her admission showed a minor disc bulge at L4/5 without evidence of nerve root compression. She had a past history of depression and smoked 20 cigarettes a day. her usual medications were venlafaxine 300 mg/day and naltrexone 50 mg/ day. She had been using intravenous heroin prior to commencing naltrexone three months earlier. however, she had ceased naltrexone for three weeks in the past month and had used heroin during this time. She had recommenced naltrexone one week prior to admission. For approximately one week she had been taking oral diazepam 5 mg three times daily, oral indomethacin 50 mg twice daily and oral tramadol 100 mg four times daily.
During the first 16 hours of her admission, she experienced no improvement in her severe pain. Management included oral diazepam 24 mg, intramuscular midazolam 10 mg, oral paracetamol 2g, subcutaneous/intravenous morphine 12.5 mg, intramuscular pethidine 25 mg, oral Aspalgin (aspirin 600 mg and codeine phosphate 16 mg) and rectal and oral indomethacin 150 mg. At 16 hours, an intravenous infusion of ketamine 100 mg/kg/hour was commenced by the acute pain management service, with some improvement in her pain.
It was initially planned to administer epidural steroid for presumed sciatic pain, however, there were indications of a possible infective aetiology to her pain. She was afebrile, but gave a history of sweating; total white cell count was 9.3 X10 9 /l (normal 4-11), C-reactive protein (CrP) 104 mg/l (normal <8) and erythrocyte sedimentation rate (ESr) 101 mm in 1 hour (normal 2-12).
At 21 hours the pain again became uncontrolled despite a 20 mg ketamine bolus. It was then decided that admission to the high dependency unit (hDU) was required for safe management of severe complex pain. She remained in hDU for the next eight days. An MrI of the lumbar spine on day one confirmed a small local disc bulge at L4/5 with no neural compression; discitis, osteomyelitis and epidural abscess were excluded. Following the MrI an epidural catheter was inserted at the L2-3 interspace, under propofol sedation. A test dose of 3 ml of 2% lignocaine was given, then a further 6 ml of 2% lignocaine. An epidural infusion of 0.125% bupivicaine was commenced at 6 ml/h. The aetiology of the pain remained unexplained, although an infective process was still suspected.
Naltrexone was continued as it was anticipated that epidural local anaesthetic would provide adequate analgesia. venlafaxine and oral diazepam were continued; all other medications including the ketamine infusion were ceased. Over the following hours, despite an adequate sensory block, further 5 ml boluses of 2% lignocaine, 0.125% bupivacaine and 0.25% bupivacaine were required to relieve pain. The epidural infusion rate was increased to 16 ml/h. Approximately six hours after epidural insertion, clonidine 1 mg/ml was added to the 0.125% bupivacaine, and intravenous ketamine 100 mg/kg/h was recommenced to help manage continuing severe pain.
At 48 hours her pain remained severe and she became febrile with a raised white cell count (15X10 9 /l). A diagnostic L4-5 lumbar puncture was performed; no organisms were found on staining or culture. Following aspiration of cerebrospinal fluid, intrathecal hyperbaric bupivacaine 5 mg and fentanyl 25 mg were administered. She experienced brief analgesia. Despite the normal lumbar MrI, a clinical diagnosis of osteomyelitis or discitis was made and she was commenced on intravenous flucloxacillin and gentamicin.
On day 3 her pain continued. The patient demonstrated dense sensory and motor block on the left, but poor block on the painful right side. The epidural catheter was withdrawn 2 cm and the bupivacaine/ clonidine infusion continued. The ketamine infusion was increased to 150 mg/kg/h and paracetomol 1g four times daily and ibuprofen 200 mg three times daily were added. A midazolam infusion was commenced at 1 mg/h, increasing to 5 mg/hour on day 4. She re-mained on venlafaxine, diazepam, paracetamol and ibuprofen for the duration of her 29 day admission.
A bone scan on day 5 identified unilateral right sacroiliitis. however, fluid aspirated from this joint under CT guidance on day 12 grew no organisms.
On day 5 the epidural catheter was removed because it was not effectively controlling the pain. Anticipating the requirement for opioid analgesia, naltrexone was not given on day 5 and ceased for the duration of her admission. The ketamine infusion was increased to 450 mg/kg/h. Morphine was commenced at 10 mg/hour intravenously following a 10 mg loading dose, and continued for two days. A propofol infusion was commenced at 12 mg/kg/minute. On day 6 analgesia appeared to be adequate; midazolam and propofol infusions were ceased, and oral clonidine was commenced 150 mg twice daily.
On day 7 the morphine infusion was ceased and patient controlled (PCA) morphine commenced with a 2.5 mg bolus. The ketamine infusion was reduced to 200 mg/kg/h. Morphine requirements were a total of 720 mg over the next seven days, weaning to 26 mg during the last 12 hours. On day 14 the PCA was ceased, oral oxycodone 10 mg four-hourly as required was commenced, with subcutaneous morphine for breakthrough pain. She experienced considerable pain on changing from PCA morphine to oral oxycodone. On day 15 ketamine was ceased and oxycodone increased to 10 to 20 mg, four hourly as required. She required oxycodone 40 to 80 mg/day and rescue subcutaneous morphine 40 to 60 mg/day until day 21. On day 22 her rescue morphine dose was ceased.
The patient was discharged on day 29 with an analgesic regimen of paracetamol 1g four times daily, ibuprofen 400 mg three times daily, oxycodone 10 mg four times daily and clonidine 150 mg twice daily. She remained on venlafaxine, diazepam and flucloxacillin. She was discharged to the care of a supportive family. her local doctor was experienced in management of opioid addiction and agreed to supervise reduction in oxycodone dose and recommencement of naltrexone.
A psychosocial history was obtained in the early days of her admission. The initial focus of treatment was relief of severe pain. Formal social work assessment was performed on day 23 and revealed that she had good social supports, but underlying issues of grief.
DISCUSSION
Naltrexone is a competitive opioid antagonist two to three times as potent as naloxone 1 . It has Therapeutic Goods Administration approval in the treatment of alcohol dependence and for formerly opioid-dependent patients who have ceased the use of opioids 2 . The usual oral daily maintenance dose of 50 mg provides effective blockade of the euphoric, analgesic and other opioid effects of 25 mg of intravenous heroin for 24 hours, and can have some effect for as long as 72 hours 2, 3 .
A patient should be opioid-free for seven to ten days before commencing naltrexone to avoid precipitation of opioid withdrawal symptoms 2, 4 . Animal studies suggest that use of naltrexone leads to upregulation of central nervous system mu receptors 5 . In the community, this loss of tolerance may lead to inadvertent lethal overdose and in clinical practice, patients who have recently ceased naltrexone may be more sensitive to opioids than expected 5, 6 .
Opinion varies as to how long to withhold naltrexone prior to the requirement for opioid analgesia in the context of elective surgery. Some suggest 72 hours whilst others as little as 24 hours 6, 7 . Alternatively, naltrexone can be continued if non-opioid analgesic strategies would suffice 8 .
high-dose opioid agonist will overcome naltrexone's competitive antagonism. Sufficient doses of opioid may be associated with severe respiratory depression and non-opioid receptor related side-effects including erythema, facial swelling and bronchoconstriction 2 . Short-acting opioid agonists should be used and the patient observed in a high dependency environment 2 . Small doses of naloxone may be used to reverse respiratory depression.
Infective sacroiliitis is uncommon, but is seen more frequently in intravenous drug users 9 . The diagnosis is often delayed 10, 11 . The presenting features include fever, low back, buttock or thigh pain, sciatica, pain walking, and tenderness over the joint 10, 12 . The infective organism is most commonly Staphylococcus aureus 11 . In intravenous drug users, gram negative organisms including Pseudomonas aeruginosa and Serratia marcesans are also seen 12 . With appropriate antibiotic therapy, the infection is usually treated successfully 12 .
Tramadol and venlafaxine both inhibit the reuptake of serotonin (5-hydroxytryptamine or 5-hT) and noradrenaline 13 . As a result, some authors have suggested using venlafaxine as an analgesic and tramadol as an antidepressant [13] [14] [15] . Caution is required in the administration of tramadol to patients already taking tricyclic antidepressants, monoamine oxidase inhibitors or selective serotonin reuptake inhibitors because of an increased risk of seizures 16, 17 . Tramadol has also been implicated in the development of serotonin syndrome in patients on selective serotonin reuptake inhibitors [18] [19] [20] [21] [22] . however, there was no evidence of serotinergic side-effects in our patient.
Epidural abscess is rare 23 . The incidence of clinically significant epidural abscess following epidural analgesia has been reported to be 1 in 1930 epidurals 24 . In the non-obstetric patient population the incidence may be even higher [25] [26] [27] . Following epidural analgesia central nervous system infection may arise by three mechanisms: (i) poor aseptic technique; (ii) by direct spread of organisms from the skin along the path of the catheter and (iii) by haematogenous spread of organisms because of bacteraemia, the presence of the epidural catheter which acts as a foreign body may increase this risk 28 . Infection in skin or tissue at or close to the site of planned needle insertion is considered a contraindication to epidural insertion [29] [30] [31] [32] . It is also recommended that epidurals be used with great caution in the presence of systemic infection or infection at another site 28, 33 .
Our case report illustrates the difficulty we encountered in providing sufficient and timely analgesia for severe pain, of uncertain aetiology, to a previously opioid-dependent patient on naltrexone. Tramadol, non-steroidal anti-inflammatory analgesics and conventional doses of opioid agonists were ineffective. Intravenous ketamine was briefly effective. Despite the suspicion of an infective process, an epidural was considered the only method likely to provide effective analgesia. Epidural local anaesthetic alone was also ineffective and required the addition of clonidine and intravenous ketamine to achieve adequate analgesia. After cessation of naltrexone and removal of the epidural catheter, a combination of analgesics including opioids were required. This patient initially had apparently adequate sensory block without achieving comprehensive analgesia and eventually developed a unilateral epidural block. The diagnosis of sacroiliitis was made the same day as the epidural was removed. Sensation from the sacroiliac joint is mediated via the L4-S1 nerve roots 34 which can be difficult to block 35 . Specific sensory levels were not documented. It is possible that there was sensory block in the lower thoracic and upper lumbar dermatomes but the calf, dorsum and sole of foot may not have been adequately assessed.
This patient's analgesia may have been better managed if a clear plan had been developed and documented early in her hospital stay. It is possible that the structure of our acute pain management service at that time complicated the treatment. Different consultants and registrars were responsible on different days. however, admission to hDU facilitated more rapid analgesic assessment and safe pharmacological management.
Naltrexone was not ceased on admission because it was initially felt that effective analgesia could be provided without the use of opioids. Doing so would have improved the efficacy of opioid analgesia following the cessation of the epidural infusion. After morphine PCA cessation, oral sustained release oxycodone could have been used in combination with "breakthrough" immediate release oxycodone, rather than a combination of oral and parenteral opioids. Avoidance of the subcutaneous route would have reduced painful injections to the patient and the risk of injections including infection of the injection site and needle-stick injury to staff.
Analgesia for patients on naltrexone requires a multidisciplinary approach. It is prudent to cease naltrexone 24 to 72 hours prior to elective surgery requiring opioid analgesia. In an emergency, titration of short-acting opioids in a high dependency environment is recommended. rEFErENCES
